# Philippe Ruszniewski

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philippe-ruszniewski/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,291 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 98 |
| i10-index | 312 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5113985918 |
| Works | 706 |

## Researcher papers

Showing 12 of 28.

- [Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors](https://scholariq.org/papers/phase-3-trial-of-sup-177-sup-lu-dotatate-for-midgut-neuroendocrine-tumors/)
- [Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/sunitinib-malate-for-the-treatment-of-pancreatic-neuroendocrine-tumors/)
- [Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors](https://scholariq.org/papers/lanreotide-in-metastatic-enteropancreatic-neuroendocrine-tumors/)
- [Gastroenteropancreatic neuroendocrine tumours](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-tumours/)
- [Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids](https://scholariq.org/papers/pulmonary-neuroendocrine-carcinoid-tumors-european-neuroendocrine-tumor-society/)
- [Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial](https://scholariq.org/papers/daily-oral-everolimus-activity-in-patients-with-metastatic-pancreatic/)
- [Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system](https://scholariq.org/papers/consensus-report-on-the-use-of-somatostatin-analogs-for-the-management-of/)
- [Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies](https://scholariq.org/papers/impact-of-chemoradiotherapy-after-disease-control-with-chemotherapy-in-locally/)
- [ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms](https://scholariq.org/papers/enets-consensus-guidelines-update-for-gastroduodenal-neuroendocrine-neoplasms/)
- [Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-neuroendocrine-gastrointestinal/)
- [TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study](https://scholariq.org/papers/tnm-staging-of-neoplasms-of-the-endocrine-pancreas-results-from-a-large/)
- [Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <sup>177</sup>Lu-Dotatate in the Phase III NETTER-1 Trial](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-progressive-midgut/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.